Showing results (491-500 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|September 11, 2013
Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial)M Elbendary, O M El-Gamal, M G Soliman, et al.
Prostate Cancer and Prostatic Diseases|July 17, 2026
Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathologyMohamad Watfa, Kristina Dortche, Gagan Fervaha, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2026
Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 casesZ Mian, T Gianduzzo, B Kua, et al.
Prostate Cancer and Prostatic Diseases|October 12, 2022
Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registryGijs P A van den Bergh, Malou C P Kuppen, Hans M Westgeest, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2014
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patientsF Moltzahn, J Karnes, P Gontero, et al.
Prostate Cancer and Prostatic Diseases|October 28, 2015
Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion statusJ L Wright, L Chéry, S Holt, et al.
Prostate Cancer and Prostatic Diseases|June 22, 2016
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cellsC Morell, A Bort, D Vara, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challengesS P Rowe, M A Gorin, M E Allaf, et al.
Prostate Cancer and Prostatic Diseases|June 13, 2012
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancerC J Paller, X Ye, P J Wozniak, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2014
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancerM Valerio, P D Stricker, H U Ahmed, et al.
Pageof 199